6
Participants
Start Date
February 29, 2008
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
Placebo
2 Placebo tablets, TID, orally, 58 days
20 mg ATI 7505
1 ATI 20mg and 1 placebo tablet, TID, orally, 58 days
40 mg ATI 7505
1 ATI 40mg and 1 placebo tablet, TID, orally, 58 days
80 mg ATI 7505
2 ATI 40mg tablets, TID, orally, 58 days
Research Facility, Great Neck
Research Facility, Great Neck
Research Facility, Lake Success
Research Facility, Brooklyn
Research Facility, Syracuse
Research Facility, Beaver Falls
Research Facility, Winchester
Research Facility, Winston-Salem
Research Facility, Fayetteville
Research Facility, Charleston
Research Facility, Anderson
Research Facility, Newnan
Research Facility, Savannah
Research Facility, Jacksonville
Research Facility, DeLand
Research Facility, Orlando
Research Facility, Hollywood
Research Facility, Miami
Research Facility, Boynton Beach
Research Facility, Largo
Research Facility, New Port Richey
Research Facility, Chattanooga
Research Facility, Chattanooga
Research Facility, Cincinnati
Research Facility, Dayton
Research Facility, Evansville
Research Facility, Detroit
Research Facility, Milwaukee
Research Facility, Rockford
Research Facility, Topeka
Research Facility, Monroe
Research Facility, Oklahoma City
Research Facility, Oklahoma City
Research Facility, Colleyville
Research Facility, Littleton
Research Facility, Salt Lake City
Research Facility, Los Angeles
Research Facility, Los Angeles
Research Facility, Chino
Research Facility, San Diego
Research Facility, Mission Viejo
Research Facility, Fresno
Research Facility, San Carlos
Research Facility, Ashland
Research Facility, Guelph
Research Facility, Hamilton
Research Facility, Hamilton
Research Facility, Lévis
Research Facility, Longueuil
Research Facility, Montreal
Research Facility, Ottawa
Research Facility, Québec
Research Facility, Québec
Research Facility, Québec
Research Facility, Saint-Charles-Borromée
Research Facility, Toronto
Research Facility, Birmingham
Research Facility, Cardiff
Research Facility, Coventry
Research Facility, Crewe
Research Facility, London
Research Facility, Norwich
Research Facility, Orpington
Research Facility, Salford
Collaborators (1)
ARYx Therapeutics
INDUSTRY
Procter and Gamble
INDUSTRY